These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 31247926)
21. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132 [TBL] [Abstract][Full Text] [Related]
22. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial. Kessing LV; Ziersen SC; Andersen FM; Gerds T; Budtz-Jørgensen E Acta Psychiatr Scand; 2024 May; 149(5):378-388. PubMed ID: 38379028 [TBL] [Abstract][Full Text] [Related]
23. Drugs for depressionr. Med Lett Drugs Ther; 2023 Dec; 65(1691):193-200. PubMed ID: 38133585 [No Abstract] [Full Text] [Related]
24. Effectiveness of Antidepressants in Combination with Psychotherapy. Alemi F; Soylu TG; Cannon M; McCandless C J Ment Health Policy Econ; 2024 Mar; 27(1):3-12. PubMed ID: 38634393 [TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Cipriani A; Furukawa TA; Salanti G; Geddes JR; Higgins JP; Churchill R; Watanabe N; Nakagawa A; Omori IM; McGuire H; Tansella M; Barbui C Lancet; 2009 Feb; 373(9665):746-58. PubMed ID: 19185342 [TBL] [Abstract][Full Text] [Related]
26. Duloxetine versus other anti-depressive agents for depression. Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006533. PubMed ID: 23076926 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis. Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738 [TBL] [Abstract][Full Text] [Related]
28. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
29. Are antidepressants equally effective in the long-term treatment of major depressive disorder? Buoli M; Cumerlato Melter C; Caldiroli A; Altamura AC Hum Psychopharmacol; 2015 Jan; 30(1):21-7. PubMed ID: 25393889 [TBL] [Abstract][Full Text] [Related]
30. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram]. Favré P Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis. He H; Wang W; Lyu J; Zheng J; Guo L; An X; Fan Y; Ma X J Psychiatr Res; 2018 Jan; 96():247-259. PubMed ID: 29127931 [TBL] [Abstract][Full Text] [Related]
32. Optimal doses of antidepressants in dependence on age: Combined covariate actions in Bayesian network meta-analysis. Holper L EClinicalMedicine; 2020 Jan; 18():100219. PubMed ID: 31993575 [No Abstract] [Full Text] [Related]
33. Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder. Brignone M; Diamand F; Painchault C; Takyar S Curr Med Res Opin; 2016; 32(2):351-66. PubMed ID: 26637048 [TBL] [Abstract][Full Text] [Related]
34. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani]. Gaillard R Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726 [TBL] [Abstract][Full Text] [Related]
35. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews. Monden R; Roest AM; van Ravenzwaaij D; Wagenmakers EJ; Morey R; Wardenaar KJ; de Jonge P J Affect Disord; 2018 Aug; 235():393-398. PubMed ID: 29677603 [TBL] [Abstract][Full Text] [Related]
36. Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment. Boaden K; Tomlinson A; Cortese S; Cipriani A Front Psychiatry; 2020; 11():717. PubMed ID: 32982805 [TBL] [Abstract][Full Text] [Related]
37. Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Pacher P; Kecskemeti V Curr Med Chem; 2004 Apr; 11(7):925-43. PubMed ID: 15078174 [TBL] [Abstract][Full Text] [Related]
38. A Review of Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Combined with Medication and Psychotherapy for Depression. Kochanowski B; Kageki-Bonnert K; Pinkerton EA; Dougherty DD; Chou T Harv Rev Psychiatry; 2024 May-Jun 01; 32(3):77-95. PubMed ID: 38728568 [TBL] [Abstract][Full Text] [Related]
39. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457 [TBL] [Abstract][Full Text] [Related]
40. Neurostimulation therapies in major depressive disorder: A decision-analytic model. Teng M; Khoo AL; Zhao YJ; Abdin E; Mok YM; Lim BP; Tor PC Early Interv Psychiatry; 2021 Dec; 15(6):1531-1541. PubMed ID: 33254283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]